Yongji Printing to Buy Australian Controlled Drug Supplier for AU$62 Million

MT Newswires Live
16 Dec 2024

Guizhou Yongji Printing (SHA:603058) plans to acquire Phytoca Holdings for AU$62 million, according to a Shanghai Stock Exchange filing on Saturday.

The Chinese packaging printed matter manufacturer will acquire the Australian controlled drug supplier through its second-level, wholly-owned subsidiary Y Cannabis Holdings.

Phytoca's products include finished products and semi-finished products, which are sold in the form of dried plant flowers, medical ingredient extracts, medical essential oils, medical atomization products and edible products. The company selects and purchases from overseas drug raw materials suitable for the Australian market.

Yongji Printing's shares closed 10% lower.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10